Est. 2014 · Podgorica · Montenegro

Quality medicines,
delivered with
clinical precision.

AMDIS d.o.o. is an international pharmaceutical distribution company. We partner with leading European manufacturers to bring trusted therapies to healthcare systems across the Western Balkans and the EU — with full regulatory rigour and GDP-certified logistics.

Explore portfolio → Request meeting

14 Markets served

240+ Skus distributed

EU GDP Certified since 2016

// About AMDIS

An agile partner for pharma companies entering South-East Europe.

We handle regulatory navigation, market access, GDP-compliant warehousing and last-mile distribution for international manufacturers who need a reliable local presence in the Western Balkans and the EU.

28 Specialists

11 yrs Operating

Trusted by leading manufacturers

Hemofarm
Stada
Sandoz
Novartis
GSK
Alpen Pharma

What we do

A distribution partner
that thinks like a manufacturer.

We don't just move boxes. We work alongside your regulatory, medical and commercial teams to make sure each product reaches the right patient, in the right country, with full traceability.

01 — Distribution

GDP-compliant warehousing & transport

Temperature-mapped storage, validated cold chain, and audited last-mile logistics from our hub in Podgorica to pharmacies, hospitals and wholesalers across 14 markets.

02 — Regulatory

Market access & registration

MAH transfers, national phase submissions, pharmacovigilance liaison and artwork management. We speak the language of CInMED, ALMP and HALMED.

03 — Commercial

In-market promotion & tendering

Tender participation, KOL engagement, medical education and pharmacy-level activation through our local sales force and digital channels.

240+ Products in portfolio

14 Markets served

11 yrs Operating since 2014

EU GDP Certified since 2016

Therapeutic areas

A focused portfolio
built for everyday care.

We concentrate on the chronic, high-prevalence conditions that shape modern public health — the products that physicians prescribe daily and patients rely on for life.

TA.01

Cardiovascular

42 SKUs

Antihypertensives, statins, anticoagulants and chronic heart failure therapies.

TA.02

Diabetes & Metabolism

28 SKUs

Oral antidiabetics, insulins, GLP-1 analogues and metabolic syndrome management.

TA.03

Central Nervous System

36 SKUs

Antidepressants, anxiolytics, antipsychotics and anti-epileptics.

TA.04

Respiratory

22 SKUs

Inhaled therapies, nasal sprays, antihistamines and COPD management.

TA.05

Gastroenterology

18 SKUs

PPIs, prokinetics, hepatoprotectors and IBD therapies.

TA.06

Oncology & Specialty

14 SKUs

Targeted therapies, immunomodulators and rare-disease medicines, handled in dedicated cold-chain protocols.

Our story

Founded by pharmacists,
built for manufacturers.

AMDIS was founded in 2014 by a group of pharmacists and regulatory professionals who saw the same problem from both sides: talented pharma companies struggling to enter the Western Balkans, and patients waiting too long for innovative therapies to reach them.

Today we operate from a GDP-certified warehouse in Podgorica, with active registrations in 14 countries and a team that includes pharmacists, regulatory specialists and commercial leaders who have spent their careers in the regional pharmaceutical industry.

"We measure our success in the number of patients who got the medicine they needed, on time, at the right dose." — Dr. S. Marković, Founder & CEO

Read our full story →

How we work

From dossier to patient,
in four predictable steps.

A transparent, auditable process — designed for speed, built for compliance. Every step has a named owner, a documented output, and a measured timeline.

Step 01

Scoping & feasibility

Market landscape, competitive analysis, regulatory pathway and timeline estimate within 10 business days.

Step 02

Registration

Dossier preparation, MAH transfer, national phase submissions across target markets, pharmacovigilance set-up.

Step 03

Launch readiness

Warehousing, batch certification, packaging localisation, tender submissions, sales-team onboarding.

Step 04

In-market operations

Continuous distribution, KOL engagement, quarterly business reviews, market intelligence reports.

Get in touch

Looking for a regional
distribution partner?

Whether you are launching a new molecule or expanding an existing brand, we would be glad to discuss how AMDIS can support your growth across the Balkans and the EU.

Request a meeting → See our partners

Quality medicines, delivered with clinical precision.